Cargando…

The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study

BACKGROUND: Although both type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD) are associated with increased risk of cardiovascular disease (CVD), evidence is lacking as to whether the presence of NAFLD confers an additional risk of CVD in patients with T2DM. We investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jiyun, Kim, Gyuri, Kim, Bong-Sung, Han, Kyung-Do, Kwon, So Yoon, Park, So Hee, Lee, You-Bin, Jin, Sang-Man, Kim, Jae Hyeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013458/ https://www.ncbi.nlm.nih.gov/pubmed/35429980 http://dx.doi.org/10.1186/s12933-022-01483-y

Ejemplares similares

The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study
por: Park, Jiyun, et al.
Publicado: (2022)

The association of hepatic steatosis and fibrosis with heart failure and mortality
por: Park, Jiyun, et al.
Publicado: (2021)

Risk Stratification of Advanced Fibrosis in HIV Patients With Hepatic Steatosis Using the NAFLD Fibrosis and BARD Scores
por: YENDEWA, George A., et al.
Publicado: (2023)

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Lee, Tae Hoon, et al.
Publicado: (2013)

Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019
por: Park, Jiyun, et al.
Publicado: (2023)

Low Household Income Status and Death from Pneumonia in People with Type 2 Diabetes Mellitus: A Nationwide Study
por: Lee, You-Bin, et al.
Publicado: (2023)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

Comments to Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Guan, Yong-Song
Publicado: (2014)

The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study
por: Chung, Goh Eun, et al.
Publicado: (2022)

MAFLD and NAFLD in the prediction of incident chronic kidney disease
por: Kwon, So Yoon, et al.
Publicado: (2023)

Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD
por: Park, So Hee, et al.
Publicado: (2023)

Association between cholesterol levels and dementia risk according to the presence of diabetes and statin use: a nationwide cohort study
por: Lee, You-Bin, et al.
Publicado: (2022)

Risk of early mortality and cardiovascular disease according to the presence of recently diagnosed diabetes and requirement for insulin treatment: A nationwide study
por: Lee, You‐Bin, et al.
Publicado: (2021)

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2010)

BARD1 mediates TGF-β signaling in pulmonary fibrosis
por: André, Pierre-Alain, et al.
Publicado: (2015)

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus
por: Park, Jiyun, et al.
Publicado: (2022)

BARDES coming of age?
Publicado: (2022)

Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
por: Park, Huiyul, et al.
Publicado: (2022)

Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study
por: Cho, Yun Kyung, et al.
Publicado: (2023)

Aldosterone Immunoassay-Specific Cutoff Value for Seated Saline Suppression Test for Diagnosing Primary Aldosteronism
por: Kwon, So Yoon, et al.
Publicado: (2022)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
por: Lee, Hyo Young, et al.
Publicado: (2019)

Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study
por: Lee, Sang Hoon, et al.
Publicado: (2016)

Supplementation of Abelmoschus manihot Ameliorates Diabetic Nephropathy and Hepatic Steatosis by Activating Autophagy in Mice
por: Kim, Hwajin, et al.
Publicado: (2018)

EX-527 Prevents the Progression of High-Fat Diet-Induced Hepatic Steatosis and Fibrosis by Upregulating SIRT4 in Zucker Rats
por: Kundu, Amit, et al.
Publicado: (2020)

Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability
por: Pilyugin, Maxim, et al.
Publicado: (2016)

Clinical Link between the BARD Score at Diagnosis and Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Lee, Tae-Geom, et al.
Publicado: (2023)

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
por: Rom, Oren, et al.
Publicado: (2019)

Sanguisorba officinalis L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced Mice
por: Nam, Yunseong, et al.
Publicado: (2023)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Dualistic Role of BARD1 in Cancer
por: Cimmino, Flora, et al.
Publicado: (2017)

Association between History of Pregnancy and Liver Fibrosis Using Fibrosis-4 Index in Korean Postmenopausal Women: A Nationwide Population-Based Study
por: Ahn, Jae-Joon, et al.
Publicado: (2022)

Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population
por: Chung, Jieun, et al.
Publicado: (2021)

Validation of the Simplified Acute Physiology Score 3 Scoring System in a Korean Intensive Care Unit
por: Lim, So Yeon, et al.
Publicado: (2011)

Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways
por: Lee, Seung Min, et al.
Publicado: (2022)

Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a nationwide population-based study in Korea
por: Roh, Jae-Hyung, et al.
Publicado: (2020)

Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study
por: Cho, So Hyun, et al.
Publicado: (2023)

BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1
por: Witus, Samuel R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_19cep6k39a6vjugilnlf4ghlga